Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

PHLEBI_THROMBOP_SUPERF_VESSE_LOWER_EXTREMITI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ATC codes for adverse effects of Drugs — ANY Hospital discharge: ICD-10 — I80.0# 1 out of 7 registries used, show all original rules.	114
4. Check minimum number of events None	114
5. Include endpoints None	114
6. Filter based on genotype QC (FinnGen only)	101

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	PHLEBI_THROMBOP_SUPERF_VESSE_LOWER_EXTREMITI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC	ANY
HD_ICD_10	I800
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	101	65	36
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	54.13	53.37	55.52

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
104: Matched controls
1040

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

+∞

120.1

104

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

8.6

22.5

B01AA03

ATC

warfarin; systemic

4.7

13.5

161

PHD99

NOMESCO Finland

Resection of other vein

8.7

10.2

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

9.2

9.7

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

4.2

9.2

PHD76

NOMESCO Finland

Resection of long saphenous vein

9.6

9.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.9

7.5

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

11.0

6.2

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

8.1

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

289

2.23

3.85

4.2

3.3

1.03

0.39

e6/l

0.48

204

(3018095) Leukocytes [#/volume] in Urine

377

2.22

3.85

4.9

4.3

97.19

56.75

e6/l

0.50

263

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

156

2.41

3.76

3.4

3.2

4.02

4.24

e6/l

0.03

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

171

2.36

3.75

3.6

3.1

0.86

1.31

e6/l

0.55

(3002582) Erythrocytes [#/volume] in Urine

341

2.13

3.51

3.9

3.5

26.68

40.17

e6/l

0.48

258

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

212

2.16

3.26

1.5

1.8

1.67

1.66

mg/l

0.00

178

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

361

2.03

3.13

4.8

3.5

—

(3026782) Osmolality of Urine

199

2.14

3.13

3.6

3.4

542.77

514.27

mosm/kgh2o

0.33

172

(3039162) Centromere protein B Ab [Units/volume] in Serum

10.41

3.01

1.0

1.4

—

(3021589) Normoblasts [#/volume] in Blood

387

1.75

2.08

12.6

12.5

0.00

e9/l

0.27

314

(3022096) Basophils/Leukocytes in Blood

408

1.74

2.03

5.5

5.8

0.67

0.64

0.18

382

(42870588) Differential panel, method unspecified - Blood

290

1.75

1.99

4.5

5.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

102

2.06

1.92

3.1

5.1

229.21

251.40

u/l

0.35

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

778

0.58

1.77

3.8

4.5

1.18

1.28

mmol/l

0.64

690

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.71

1.70

1.0

1.1

—

(3010421) pH of Blood

2.62

1.63

2.5

3.4

7.41

7.42

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.02

1.61

1.7

2.5

0.20

0.21

g/l

0.13

(3026008) Bacteria identified in Urine by Culture

324

1.62

1.57

4.8

3.8

—

(3019198) Lymphocytes [#/volume] in Blood

463

1.57

1.44

6.5

5.8

1.73

1.75

e9/l

0.05

408

(3001604) Monocytes [#/volume] in Blood

456

1.55

1.38

6.3

5.8

0.61

0.58

e9/l

0.43

388

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

1.37

0.0

1.9

—

24.89

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.01

1.35

1.2

2.8

11.54

9.94

g/l

0.27

(3006315) Basophils [#/volume] in Blood

459

1.54

1.32

6.3

5.8

0.04

e9/l

0.09

389

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.59

1.32

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.59

1.32

1.2

1.3

—

(3013115) Eosinophils [#/volume] in Blood

470

1.53

1.30

6.3

5.9

0.23

0.18

e9/l

1.15

408

(3020630) Protein [Mass/volume] in Serum or Plasma

1.92

1.28

3.4

3.1

69.19

66.46

g/l

0.70

(3007164) IgA [Mass/volume] in Serum or Plasma

167

1.65

1.28

1.2

1.5

2.27

2.60

g/l

0.25

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

102

1.80

1.25

3.8

4.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

820

0.63

1.25

4.7

5.3

1.46

1.52

mmol/l

0.40

735

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

680

1.59

1.21

30.1

22.8

14.00

13.94

0.12

673

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

1.18

0.0

2.1

—

(3049717) Cytology report of Urine Cyto stain

2.14

1.18

3.0

2.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

1.16

0.0

2.2

—

(3023368) Bacteria identified in Blood by Culture

278

1.51

1.15

5.2

4.8

—

(3000991) Gas panel - Venous blood

1.78

1.11

3.5

8.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.09

1.08

1.1

1.2

—

(4024509) Urine culture

2.05

1.07

2.0

1.8

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2.33

1.04

1.8

3.6

5.20

4.93

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

2.33

1.04

1.8

3.6

8.50

8.30

kpa

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

126

1.62

1.00

1.6

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

449

1.42

0.97

2.6

2.1

91.16

96.84

pmol/l

0.33

222

(3034770) Mitochondria Ab [Titer] in Serum

2.29

0.95

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

878

0.65

0.95

32.0

24.6

75.91

78.33

umol/l

0.48

870

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.83

0.94

3.3

8.6

25.92

25.49

mmol/l

0.15

(3021960) Folate [Moles/volume] in Serum or Plasma

299

1.43

0.92

2.2

1.8

21.73

22.47

nmol/l

0.09

251

(3013650) Neutrophils [#/volume] in Blood by Automated count

504

1.39

0.88

7.6

10.0

3.98

4.15

e9/l

0.25

441

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

237

1.44

0.87

2.9

2.3

2.46

2.88

mg/l

0.48

205

(3018418) pH of Serum or Plasma

331

1.39

0.85

4.2

4.3

7.40

0.18

236

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

360

1.39

0.84

1.9

2.0

1.13

1.31

mmol/l

1.40

284

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.93

0.83

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.93

0.83

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.93

0.83

1.0

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.68

0.79

3.6

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

134

1.51

0.78

1.7

1.8

—

(3013512) EKG study

345

0.71

0.78

4.3

3.8

—

(40761511) CBC panel - Blood by Automated count

844

0.70

0.78

20.2

16.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2.23

0.77

1.0

1.3

—

(3002256) Pathology report gross observation

127

1.50

0.74

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.76

0.71

1.0

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.71

0.71

1.5

1.9

—

(3035941) MCH [Entitic mass]

885

0.69

0.70

34.1

27.7

30.33

30.41

0.16

876

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

885

0.69

0.70

34.7

28.4

38.98

39.56

0.42

875

(3000963) Hemoglobin [Mass/volume] in Blood

885

0.69

0.70

34.5

28.0

129.64

132.21

g/l

0.88

875

(3024731) MCV [Entitic mean volume] in Red Blood Cells

884

0.70

0.68

34.2

27.7

92.14

91.80

0.26

875

(4034850) Laboratory test

1.82

0.67

35.6

15.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

865

0.71

0.66

29.6

22.4

3.96

3.98

mmol/l

0.20

849

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.76

0.64

1.2

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

864

0.72

0.64

29.0

22.4

140.02

139.67

mmol/l

0.65

848

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.58

0.61

1.6

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

375

1.30

0.61

3.5

2.9

93.89

134.53

ug/l

1.56

342

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.59

0.0

1.5

—

(40758558) Short blood count panel - Blood

309

1.31

0.59

3.4

6.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

797

0.75

0.59

25.8

18.7

75.02

73.36

ml/min/173m2

0.31

744

(3035350) Ketones [Presence] in Urine by Test strip

486

1.28

0.56

5.0

4.6

0.00

16.08

estimate

0.50

101

(3017732) Neutrophils [#/volume] in Blood

0.58

0.55

4.7

2.5

3.61

4.58

e9/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.57

0.55

1.8

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

490

1.26

0.51

5.0

4.6

0.00

estimate

-0.00

(3029937) Albumin [Presence] in Urine by Test strip

272

0.76

0.50

6.1

4.8

0.00

estimate

—

(40761535) Cells panel - Urine sediment

0.59

0.48

8.0

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

105

1.39

0.44

1.6

1.8

—

(3015736) pH of Urine

378

1.23

0.43

4.5

4.3

6.15

6.30

0.29

206

(40768800) Prostate Pathology biopsy report

0.00

0.41

0.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3012516) Albumin [Mass/volume] in Urine

318

0.80

0.41

3.5

3.1

13.17

33.49

mg/l

2.05

202

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

479

1.22

0.40

4.8

4.6

0.00

estimate

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.40

0.0

2.3

—

2.86

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.40

0.0

2.1

—

(3022145) Colonoscopy Study observation

1.39

0.40

1.1

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.2

—

(40768443) Skin Pathology biopsy report

1.49

0.37

1.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

281

0.81

0.34

3.7

—

(3003694) ABO and Rh group [Type] in Blood

228

0.80

0.34

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

102

1.31

0.31

1.2

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

528

1.18

0.31

4.1

6.2

9.92

12.04

umol/l

1.93

501

(3019150) Specific gravity of Urine by Refractometry

215

1.21

0.30

5.4

5.0

1.02

kg/l

0.27

143

(3012544) pH of Venous blood

103

1.30

0.30

4.0

3.0

7.40

7.39

—

(3020682) Albumin/Creatinine [Ratio] in Urine

327

0.84

0.28

4.3

3.7

2.40

6.47

mg/mmol

1.72

192

(3000492) Spirometry study

0.70

0.27

1.2

1.6

—

(40761536) Microorganisms panel - Urine sediment

1.27

0.26

3.1

4.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.70

0.25

1.7

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

791

0.85

0.24

7.0

5.6

1.88

1.94

mu/l

0.16

711

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

174

1.19

0.22

1.6

2.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.21

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.21

0.0

1.2

—

19.46

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.21

0.0

2.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.21

0.0

4.7

—

663.42

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

5.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

0.21

0.0

2.4

—

16.29

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

2.0

—

8.61

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.27

0.20

2.3

2.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

3.6

—

134.84

—

(3044640) Blood type and Crossmatch panel - Blood

312

1.13

0.19

2.8

2.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

120

1.19

0.17

2.3

3.7

1.61

1.88

1.02

109

(3008152) Bicarbonate [Moles/volume] in Arterial blood

0.71

0.17

7.0

5.3

23.22

24.68

mmol/l

—

(40768797) Stomach Pathology biopsy report

131

1.17

0.15

1.2

—

(3000494) Fungus identified in Specimen by Culture

112

1.18

0.15

1.3

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

123

1.16

0.13

3.6

7.6

13.31

11.77

kpa

0.29

116

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

123

1.16

0.13

3.6

7.6

4.82

5.12

kpa

0.78

116

(3016502) Oxygen saturation in Arterial blood

116

0.85

0.12

4.6

7.7

97.93

95.70

—

111

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

432

0.92

0.12

2.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.18

0.12

1.5

2.1

333.45

374.57

nmol/l

0.32

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

232

1.10

0.11

2.6

2.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.09

0.10

1.6

2.0

10.58

12.01

nmol/l

—

(36660697) Celiac disease serology panel - Serum

1.06

0.08

1.2

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.03

0.07

1.1

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.87

0.07

1.1

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

384

0.94

0.06

5.2

4.3

24.93

51.83

ng/l

1.41

302

(3041096) Erythrocytes [Presence] in Urine by Automated

262

0.94

0.05

3.9

4.1

0.00

estimate

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

110

0.90

0.05

1.6

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

191

0.93

0.05

8.4

5.2

—

(40768804) Tissue Pathology biopsy report

379

1.05

0.04

2.3

2.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

137

0.94

0.01

2.8

3.1

0.77

1.00

ug/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

176

0.96

0.00

3.2

4.4

28.44

22.29

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

226

0.97

0.00

5.6

5.2

1.70

2.60

ug/l

0.70

196

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

422

0.99

0.00

2.8

2.7

—

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

361

1.00

0.00

4.8

4.7

0.11

0.01

estimate

—

(3042936) Bacteria identified in Isolate by Culture

135

1.04

0.00

2.9

2.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

155

1.04

0.00

2.2

1.7

35.78

29.63

0.86

148

(4035726) Immunohistochemistry procedure

1.05

0.00

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.98

-0.00

1.2

1.4

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

-0.00

0.0

2.2

—

43.67

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3019060) Gas panel - Arterial blood

1.00

-0.00

3.3

3.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

7.3

—

209.17

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

-0.00

0.0

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.90

-0.00

1.0

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

-0.00

0.0

6.4

—

43.30

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

3.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.93

-0.00

1.7

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

2.0

—

17.10

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

37.87

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

310

1.00

-0.00

1.9

2.2

110.45

217.08

u/l

3.30

297

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.0

—

(3003129) Base excess in Capillary blood by calculation

0.00

-0.00

0.0

1.7

—

-0.52

—

(3006270) Folate [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

371.00

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(3025941) Bacteria identified in Stool by Culture

1.02

-0.00

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.9

—

8.43

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

11.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

1.95

—

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: PHLEBI_THROMBOP_SUPERF_VESSE_LOWER_EXTREMITI – Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced (PHLEBI_THROMBOP_SUPERF_VESSE_LOWER_EXTREMITI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints